16th International Symposium of Trace Elements in man and Animals
Philippe Collery, MD, PhD

Philippe Collery, MD, PhD

Medical Doctor (MD), Specialist in Internal Medicine, Oncologist,
Dr. in Pharmacology (PhD)
Habilitation to supervise Researches

Affiliation and position:

Society for the Coordination of Therapeutic Researches, Algajola, France - Manager

Research interests:

  1. Development of a new rhenium (I)-diselenoether compound for the treatment of cancer (a water soluble metal-based anticancer drug with one atom of rhenium and two atoms of selenium).
  2. the role of metals and trace elements in cancer

Key publications for the last 5 years:

  1. Collery P, Santoni F, Mohsen A, Mignard C, and Desmaele D: Negative Impact of Total Body Irradiation on the Antitumor Activity of Rhenium-(I)-diselenoether. Anticancer Res 36: 5813-5819, 2016.
  2. Collery P, Santoni F, Ciccolini J, Tran TN, Mohsen A, and Desmaele D: Dose Effect of Rhenium (I)-diselenoether as Anticancer Drug in Resistant Breast Tumor-bearing Mice After Repeated Administrations. Anticancer Res 36: 6051-6057, 2016.
  3. Collery P, Mohsen A, Kermagoret A, Corre S, Bastian G, Tomas A, Wei M, Santoni F, Guerra N, Desmaele D, and d'Angelo J: Antitumor activity of a rhenium (I)-diselenoether complex in experimental models of human breast cancer. Invest New Drugs 33: 848-860, 2015.
  4. Philippe Collery, Gérard Bastian, François Santoni, Ahmed Mohsen, Ming Wei, Thomas Collery, Alain Tomas, Didier Desmaele, and Jean D’Angelo: Uptake and Efflux of Rhenium in Cells Exposed to Rhenium Diseleno-Ether and Tissue Distribution of Rhenium and Selenium after Rhenium Diseleno-Ether Treatment in Mice. Anticancer Res 34: 1679-1690, 2014.
  5. Collery P, D'Angelo J, and Morgant G: Rhenium complexes and their pharmaceutical use- US Patent N° 8987491B2. In: March 24, 2015 (Patent US ed.). USA, 2015.

Journal referee:

  1. Bioorganic and Medicinal Chemistry, Elsevier
  2. BBA- Molecular Cell Research, Elsevier
  3. European Journal of Medicinal Chemistry, Elsevier
  4. Investigational New Drugs, Springer

Scientific societies:

  1. Association for the Research and Development of Organo-Metallic Complexes
  2. Pharmacological Clinical Oncological Group

Personal web-page (Institutional/ResearchGate/LinkedIn): Linkedin and ResearchGate